# 415 CAPITAL

415 CAPITAL is a Private Equity based in Munich, Germany.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Munich, Germany
- **Region:** Europe
- **Address:** Munich, Germany
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** www.415capital.com
- **LinkedIn:** https://www.linkedin.com/company/415-capital

## Regulatory record

- **Reports private funds:** No

## About

415 Capital is a venture capital firm investing in medical innovations within the medical technology sector. It provides capital and support to entrepreneurs developing technologies addressing patient needs, particularly in cardio and neurovascular disorders. 415 Capital is based in Oberhaching, Germany, and has made 18 investments, including a Series C investment in Endovascular Engineering on April 07, 2026.

## Questions

### What is 415 CAPITAL's investment strategy?

415 CAPITAL pursues a venture and growth-stage investment strategy concentrated exclusively on the medical technology sector, with a specific emphasis on cardiovascular innovation. The firm invests from early seed rounds through to late-stage expansion, taking an active, direct equity approach.

### What geographic markets does 415 CAPITAL target?

The firm is headquartered in Munich, Germany, and operates from this European base. While its primary strategic anchor is the European medical technology cluster, the firm's stage-agnostic mandate does not preclude cross-border investments within its narrow sector focus.

### Which sectors does 415 CAPITAL explicitly avoid?

The firm’s strategy is exclusively geared toward medical technology, specifically cardiovascular solutions. It implicitly avoids all sectors outside of medtech, such as enterprise software, consumer technology, or general industrial tech, maintaining a highly concentrated, single-sector playbook.

### How does 415 CAPITAL source its proprietary deal flow?

The firm’s deep, single-sector focus on cardiovascular medtech is its primary sourcing advantage. By concentrating its network, research, and technical diligence within one niche, 415 CAPITAL aims to access opportunities through specialized clinical, academic, and industry channels in Europe rather than competing in broad, multi-sector auctions.

## Related profiles

- [412 Venture Fund](https://altss.com/profile/412-venture-fund)
- [424 Capital](https://altss.com/profile/424-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/415-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology